Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

TxSCO ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
NCOA ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
MJ14-CME-Opportunities
Hospitals under Health Reform Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Hospitals under Health Reform Robert T. Clarke To cite this article: Robert T. Clarke (1993) Hospitals …
Using Clinical Financial Pathways to Capitate Cancer Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Using Clinical Financial Pathways to Capitate Cancer Kent Giles To cite this …
Running toward Life's Roar Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Running toward Life's Roar Lee E. Mortenson To cite this article: Lee E. Mortenson (1997) Running toward …
3/21/22, 3:36 PM Who Should Attend https://www.accc-cancer.org/home/attend/accc-48th-annual-meeting-cancer-center-business-summit/about/who-should-attend 1/2   Healthcare is ever-changing, and we need to be actively involved in the transformation. This meeting has a unique way of opening up viewpoints and letting everyone know— regardless of care setting—that we are all in the same …
Home / Optional Events Optional Events ACCC National Oncology Conference: Optional Evening Events Please indicate your interest on the National Oncology Conference registration form, or when registering online, select the appropriate checkbox under "Optional Events" to complete your event registration. New Member Meet and Greet New Member Meet and Greet Wednesday, October 19, …
CCMED_7_10_Infographic_Oct_14_2020 Improving Non-Small Cell Lung Cancer Care Delivery: Learnings for Oncology Nurses and Patient Navigation From a National Quality Survey Aversano et al. (2020) How Patient Navigation Models in Non-Small Cell Lung Cancer Care Programs in the US Can Be Improved BREAST CANCER PROGRAM NAME SUPPORTING TEXT CAN GO HERE, MORE SUPPORT TEXT …
PowerPoint Presentation Cross-Functional Communication to Improve Revenue Cycle Management Angie Santiago, CRCS Manager, Oncology Financial Advocacy Sidney Kimmel Cancer Center at the Thomas Jefferson University Health System Agenda Review the revenue lifecycle, beginning at scheduling and ending with payers’ payment(s). Build understanding of each step of the revenue-cycle process. Revenue …
10 accc-cancer.org | Vol. 37, No. 3, 2022 | OI S eacoast Cancer Center at Wentworth- Douglass Hospital is located inland from the Atlantic Ocean and Great Bay of New Hampshire in Dover, N.H, and its full-service satellite sits closer to the coast in the beautiful and historic seaside city of Portsmouth, N.H. The cancer center’s strategic location, scope, quality of services, and personalized …
A curbside clinic offers patients another option for accessing cancer care | 44 Tailoring distress screening to meet the needs of specific patient populations | 30 This publication is a benefit of membership Association of Community Cancer Centers Vol. 36 | No. 5 | 2021 Creating an oncology practice plan that can change with the times | 24 ISSUES ONCOLOGY A digital screening …
1 Association of Community Cancer Centers Increase the Identification of Patients Who may be Eligible for Clinical Trials Problem Statement Root Causes Patients with advanced lung cancer are not being referred for clinical trial opportunities • Patients may have misconceptions about clinical trials • Lack of awareness about open clinical trials • Oncologists may be reluctant …
To download these images, simply right-click and save to your computer. Use these images with pre-written social media posts or craft your own message. Please include the official meeting hashtag (#AMCCBS) and URL (https://bit.ly/2022AMCCBS) so it can be searchable in the overall meeting promotions. Twitter & LinkedIn Graphics
To download these images, simply right-click and save to your computer. Use these images with pre-written social media posts (or craft your own message). Please include the official meeting hashtag (#AMCCBS) and URL (http://bit.ly/2022AMCCBS) so it can be searchable in the overall meeting promotions. Twitter & LinkedIn Graphics
Patient Education Videos This patient education videos series, available in two Philippine dialects (Tagalog and Ilocano), was developed by the Hawaii Society of Clinical Oncology (HSCO). These videos were produced with funding from the American Society of Clinical Oncology (ASCO) through a grant to the Hawaii Society of Clinical Oncology and OnCare Hawaii. Additional funding was provided by the Friends …
Listen as Cindy Varga, MD, discusses the positives and negatives with subcutaneous versus intravenous drugs in treating patients with multiple myeloma.
The 2023-2024 ACCC President’s Theme is (Re)Building the Oncology Workforce to Deliver Next Generation Cancer Care.
As biomarker testing can play a critical role in the diagnosis of rare cancers, such as NTRK gene fusion-positive cancers, hear what care teams need to know about identifying patients who may be eligible for this testing.